Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, United States.
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1094-124. doi: 10.1016/j.addr.2010.09.002. Epub 2010 Sep 19.
Theranostics, the fusion of therapy and diagnostics for optimizing efficacy and safety of therapeutic regimes, is a growing field that is paving the way towards the goal of personalized medicine for the benefit of patients. The use of light as a remote-activation mechanism for drug delivery has received increased attention due to its advantages in highly specific spatial and temporal control of compound release. Photo-triggered theranostic constructs could facilitate an entirely new category of clinical solutions which permit early recognition of the disease by enhancing contrast in various imaging modalities followed by the tailored guidance of therapy. Finally, such theranostic agents could aid imaging modalities in monitoring response to therapy. This article reviews recent developments in the use of light-triggered theranostic agents for simultaneous imaging and photoactivation of therapeutic agents. Specifically, we discuss recent developments in the use of theranostic agents for photodynamic-, photothermal- or photo-triggered chemotherapy for several diseases.
治疗与诊断的融合——治疗策略的疗效和安全性优化的靶向治疗,是一个不断发展的领域,为了患者的利益,正在朝着个性化药物的目标迈进。由于用光作为药物输送的远程激活机制具有在化合物释放方面进行高度特异性时空控制的优势,因此越来越受到关注。光触发治疗诊断构建体可以通过在各种成像模式下增强对比度来早期识别疾病,从而为临床治疗提供全新的解决方案,然后对治疗进行针对性的指导。最后,此类治疗诊断试剂可以帮助成像模式监测对治疗的反应。本文综述了光触发治疗诊断试剂在同时进行成像和光激活治疗试剂方面的最新进展。具体而言,我们讨论了用于几种疾病的光动力、光热或光触发化学疗法的治疗诊断试剂的最新进展。